Premature aging in childhood cancer survivors (Review)
- Authors:
- Jarmila Kruseova
- Andrea Zichova
- Tomas Eckschlager
-
Affiliations: Department of Pediatric Hematology and Oncology, 2nd Medical Faculty, Charles University and University Hospital Motol, 150 06 Prague, Czech Republic - Published online on: December 13, 2022 https://doi.org/10.3892/ol.2022.13629
- Article Number: 43
This article is mentioned in:
Abstract
|
Calaminus G, Baust K, Berger C, Byrne J, Binder H, Casagranda L, Grabow D, Grootenhuis M, Kaatsch P, Kaiser M, et al: Health-related quality of life in european childhood cancer survivors: Protocol for a study within PanCareLIFE. JMIR Res Protoc. 10:e218512021. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL and Mertens AC: Late mortality among 5-year survivors of childhood cancer: A summary from the childhood cancer survivor study. J Clin Oncol. 27:2328–2338. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bhuller KS, Zhang Y, Li D, Sehn LH, Goddard K, Mcbride ML and Rogers PC: Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: Report of the childhood/adolescent/young adult cancer survivors research program and the BC cancer agency centre for lymphoid cancer. Br J Haematol. 172:757–768. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Oeffinger KC and Hudson MM: Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors. CA Cancer J Clin. 54:208–236. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LC, Kuehni CE, Auquier P, Michel G, de Vathaire F, et al: Childhood cancer survivor cohorts in Europe. Acta Oncol. 54:655–668. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor A, Hawkins M, Griffiths A, Davies H, Douglas C, Jenney M, Wallace WH and Levitt G: Long-term follow-up of survivors of childhood cancer in the UK. Pediatr Blood Cancer. 42:161–168. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Konończuk K, Latoch E, Żelazowska-Rutkowska B, Krawczuk-Rybak M and Muszyńska-Rosłan K: Increased levels of adipocyte and epidermal fatty acid-binding proteins in acute lymphoblastic leukemia survivors. J Clin Med. 10:15672021. View Article : Google Scholar : PubMed/NCBI | |
|
Armenian SH, Gibson CJ, Rockne RC and Ness KK: Premature aging in young cancer survivors. J Natl Cancer Inst. 111:226–232. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, Sklar CA, Robison LL and Oeffinger KC: Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 32:1218–1227. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kruseová J, Gottfriedová B, Zichová A, Švojgr K, Hošek P, Lukš A, Kynčl M and Eckschlager T: Is there a higher incidence of sporadic renal angiomyolipoma in childhood cancer survivors? Clin Epidemiol. 13:707–716. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, Yeazel M, Recklitis CJ, Marina N, Robison LR, et al: Health status of adult long-term survivors of childhood cancer: A report from the childhood cancer survivor study. JAMA. 290:1583–1592. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, Haupt R, et al: Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: Investigating dose-effect relationships in a European case-control study (PanCareLIFE). Hum Reprod. 36:1561–1573. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zichová A, Eckschlager T, Ganevová M, Malinová B, Lukš A and Kruseová J: Subsequent neoplasms in childhood cancer survivors. Cancer Epidemiol. 68:1017792020. View Article : Google Scholar : PubMed/NCBI | |
|
Beekman M, Uh HW, van Heemst D, Wuhrer M, Ruhaak LR, Gonzalez-Covarrubias V, Hankemeier T, Houwing-Duistermaat JJ and Slagboom PE: Classification for longevity potential: The use of novel biomarkers. Front Public Health. 4:2332016. View Article : Google Scholar : PubMed/NCBI | |
|
De la Fuente M: Role of neuroimmunomodulation in aging. Neuroimmunomodulation. 15:213–223. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Prizment A, Thyagarajan B and Blaes A: Cancer treatment-induced accelerated aging in cancer survivors: Biology and assessment. Cancers (Basel). 13:4272021. View Article : Google Scholar : PubMed/NCBI | |
|
Stelwagen J, Lubberts S, Steggink LC, Steursma G, Kruyt LM, Donkerbroek JW, van Roon AM, van Gessel AI, van de Zande SC, Meijer C, et al: Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy. Br J Cancer. 123:1599–1607. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Wang F, Shi L, Cai H, Zheng Y, Zheng W, Bao P and Shu XO: Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence. Breast Cancer Res Treat. 180:449–459. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Dixon SB, Chen Y, Yasui Y, Pui CH, Hunger SP, Silverman LB, Ness KK, Green DM, Howell RM, Leisenring WM, et al: Reduced morbidity and mortality in survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Clin Oncol. 38:3418–3429. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Bøhn SH, Thorsen L, Kiserud CE, Fosså SD, Lie HC, Loge JH, Wisløff T, Haugnes HS and Reinertsen KV: Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood. Acta Oncol. 58:753–762. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, Barclay M, Brimicombe J, Thiemann P, McCabe MG, et al: Cancer-related fatigue in adolescents and young adults after cancer treatment: Persistent and poorly managed. J Adolesc Young Adult Oncol. 6:489–493. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
López-Otín C, Blasco MA, Partridge L, Serrano M and Kroeme G: The hallmarks of aging. Cell. 153:1194–1217. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kuilman T, Michaloglou C, Mooi WJ and Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hayflick L and Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res. 25:585–621. 1961. View Article : Google Scholar : PubMed/NCBI | |
|
Blackburn EH and Szostak JW: The molecular structure of centromeres and telomeres. Annu Rev Biochem. 53:163–194. 1984. View Article : Google Scholar : PubMed/NCBI | |
|
Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al: Mutational landscape and significance across 12 major cancer types. Nature. 502:333–339. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Knudsen ES, Nambiar R, Rosario SR, Smiraglia DJ, Goodrich DW and Witkiewicz AK: Pan-cancer molecular analysis of the RB tumor suppressor pathway. Commun Biol. 3:1582020. View Article : Google Scholar : PubMed/NCBI | |
|
Huan T, Chen G, Liu C, Bhattacharya A, Rong J, Chen BH, Seshadri S, Tanriverdi K, Freedman JE, Larson MG, et al: Age-associated microRNA expression in human peripheral blood is associated with all-cause mortality and age-related traits. Aging Cell. 17:e126872018. View Article : Google Scholar : PubMed/NCBI | |
|
Saul D and Kosinsky RL: Epigenetics of aging and aging-associated diseases. Int J Mol Sci. 22:4012021. View Article : Google Scholar : PubMed/NCBI | |
|
Vijg J: Somatic mutations, genome mosaicism, cancer and aging. Curr Opin Genet Dev. 26:141–149. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ness KK, Kirkland JL, Gramatges MM, Wang Z, Kundu M, McCastlain K, Li-Harms X, Zhang J, Tchkonia T, Pluijm SMF and Armstrong GT: Premature physiologic aging as a paradigm for understanding increased risk of adverse health across the lifespan of survivors of childhood cancer. J Clin Oncol. 36:2206–2215. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, et al: Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 309:481–484. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM and Chan DC: Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 141:280–289. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, et al: Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood. 98:2043–2051. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Rossi DJ, Jamieson CHM and Weissman IL: Stems cells and the pathways to aging and cancer. Cell. 132:681–696. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Flach J, Bakker ST, Mohrin M, Conroy PC, Pietras EM, Reynaud D, Alvarez S, Diolaiti ME, Ugarte F, Forsberg EC, et al: Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 512:198–202. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE and Scadden DT: Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 443:421–426. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jaul E and Barron J: Characterizing the heterogeneity of aging: A vision for a staging system for aging. Front Public Health. 9:5135572021. View Article : Google Scholar : PubMed/NCBI | |
|
Horvath S: DNA methylation age of human tissues and cell types. Genome Biol. 14:R1152013. View Article : Google Scholar : PubMed/NCBI | |
|
Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al: Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 49:359–367. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Levine ME, Hosgood HD, Chen B, Absher D, Assimes T and Horvath S: DNA methylation age of blood predicts future onset of lung cancer in the women's health initiative. Aging (Albany NY). 7:690–700. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, Hou L, Baccarelli AA, Li Y, Stewart JD, et al: DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 11:303–327. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Garagnani P, Bacalini MG, Pirazzini C, Gori D, Giuliani C, Mari D, Di Blasio AM, Gentilini D, Vitale G, Collino S, et al: Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell. 11:1132–1134. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng Y, Joyce BT, Colicino E, Liu L, Zhang W, Dai Q, Shrubsole MJ, Kibbe WA, Gao T, Zhang Z, et al: Blood epigenetic age may predict cancer incidence and mortality. EBioMedicine. 5:68–73. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, et al: An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 10:573–591. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kresovich JK, Xu Z, O'Brien KM, Weinberg CR, Sandler DP and Taylor JA: Methylation-based biological age and breast cancer risk. J Natl Cancer Inst. 111:1051–1058. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Durso DF, Bacalini MG, Sala C, Pirazzini C, Marasco E, Bonafé M, do Valle ÍF, Gentilini D, Castellani G, Faria AMC, et al: Acceleration of leukocytes' epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer. Oncotarget. 8:23237–23245. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qin N, Li Z, Song N, Wilson CL, Easton J, Mulder H, Plyler E, Neale G, Walker E, Zhou X, et al: Epigenetic age acceleration and chronic health conditions among adult survivors of childhood cancer. J Natl Cancer Inst. 113:597–605. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Johnson AA, Shokhirev MN, Wyss-Coray T and Lehallier B: Systematic review and analysis of human proteomics aging studies unveils a novel proteomic aging clock and identifies key processes that change with age. Aging Res Rev. 60:1010702020. View Article : Google Scholar : PubMed/NCBI | |
|
Tanaka T, Biancotto A, Moaddel R, Moore AZ, Gonzalez-Freire M, Aon MA, Candia J, Zhang P, Cheung F, Fantoni G, et al: Plasma proteomic signature of age in healthy humans. Aging Cell. 17:e127992018. View Article : Google Scholar : PubMed/NCBI | |
|
Solovev IA, Shaposhnikov MV and Moskalev A: An overview of the molecular and cellular biomarkers of aging. Healthy Ageing and Longevity. Springer Nature. (Berlin/Heidelberg, Germany). 67–78. 2019. View Article : Google Scholar | |
|
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 92:9363–9367. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Hurria A, Jones L and Muss HB: Cancer treatment as an accelerated aging process: Assessment, biomarkers, and interventions. Am Soc Clin Oncol Educ Book. 35:e516–e522. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shen J, Song R, Fuemmeler BF, McGuire KP, Chow WH and Zhao H: Biological aging marker p16INK4a in T cells and breast cancer risk. Cancers (Basel). 12:31222020. View Article : Google Scholar : PubMed/NCBI | |
|
Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, Ibrahim JG, Jolly TA, Williams G, Carey LA, et al: Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst. 106:dju0572014. View Article : Google Scholar : PubMed/NCBI | |
|
Smitherman AB, Wood WA, Mitin N, Ayer Miller VL, Deal AM, Davis IJ, Blatt J, Gold SH and Muss HB: Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16INK4a and frailty. Cancer. 126:4975–4983. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wood WA, Krishnamurthy J, Mitin N, Torrice C, Parker JS, Snavely AC, Shea TC, Serody JS and Sharpless NE: Chemotherapy and stem cell transplantation increase p16INK4a expression, a biomarker of T-cell aging. EBioMedicine. 11:227–238. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bourlon MT, Velazquez HE, Hinojosa J, Orozco L, Rios-Corzo R, Lima G, Llorente L, Hernandez-Ramirez DF, Valentin-Cortez FJ, Medina-Rangel I and Atisha-Fregoso Y: Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy. BMC Cancer. 20:8822020. View Article : Google Scholar : PubMed/NCBI | |
|
Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL, Sklar CA, et al: Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude Lifetime cohort study. J Clin Oncol. 31:4496–4503. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Degesys N, Klein C, Binner M, Browner I and Shapiro G: Fitness screening in older cancer patients. J Am Geriatr Soc. 59:S1412011. | |
|
Collard RM, Boter H, Schoevers RA and Oude Voshaar RC: Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc. 60:1487–1492. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ness KK and Wogksch MD: Frailty and aging in cancer survivors. Transl Res. 221:65–82. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Williams AM, Krull KR, Howell CR, Banerjee P, Brinkman TM, Kaste SC, Partin RE, Srivastava D, Yasui Y, Armstrong GT, et al: Physiologic frailty and neurocognitive decline among young-adult childhood cancer survivors: A prospective study from the St Jude lifetime cohort. J Clin Oncol. 39:3485–3495. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hayek S, Gibson TM, Leisenring WM, Guida JL, Gramatges MM, Lupo PJ, Howell RM, Oeffinger KC, Bhatia S, Edelstein K, et al: Prevalence and predictors of frailty in childhood cancer survivors and siblings: A report from the childhood cancer survivor study. J Clin Oncol. 38:232–247. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Vatanen A, Hou M, Huang T, Söder O, Jahnukainen T, Kurimo M, Ojala TH, Sarkola T, Turanlahti M, Saarinen-Pihkala UM and Jahnukainen K: Clinical and biological markers of premature aging after autologous SCT in childhood cancer. Bone Marrow Transplant. 52:600–605. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kruseova J, Vicha A, Feriancikova B and Eckschlager T: Possible mechanisms of subsequent neoplasia development in childhood cancer survivors: A review. Cancers (Basel). 13:50642021. View Article : Google Scholar : PubMed/NCBI | |
|
Wilson CL, Chemaitilly W, Jones KE, Kaste SC, Srivastava DK, Ojha RP, Yasui Y, Pui CH, Robison LL, Hudson MM and Ness KK: Modifiable factors associated with aging phenotypes among adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 34:2509–2515. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bennett JA, Winters-Stone KM, Dobek J and Nail LM: Frailty in older breast cancer survivors: Age, prevalence, and associated factors. Oncol Nurs Forum. 40:E126–E134. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Smitherman AB, Anderson C, Lund JL, Bensen JT, Rosenstein DL and Nichols HB: Frailty and comorbidities among survivors of adolescent and young adult cancer: A cross-sectional examination of a hospital-based survivorship cohort. J Adolesc Young Adult Oncol. 7:374–383. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chemaitilly W, Cohen LE, Mostoufi-Moab S, Patterson BC, Simmons JH, Meacham LR, van Santen HM and Sklar CA: Endocrine late effects in childhood cancer survivors. J Clin Oncol. 36:2153–2159. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SJ and Kim NC: Association between sarcopenia and metabolic syndrome in cancer survivors. Cancer Nurs. 40:479–487. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SJ, Park YJ and Cartmell KB: Sarcopenia in cancer survivors is associated with increased cardiovascular disease risk. Support Care Cancer. 26:2313–2321. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Felicetti F, Aimaretti E, Dal Bello F, Gatti F, Godono A, Saba F, Einaudi G, Collino M, Fagioli F, Aragno M and Brignardello E: Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications. Free Radic Biol Med. 178:76–82. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Sadowska-Bartosz I and Bartosz G: Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 160:1–18. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ariffin H, Azanan MS, Abd Ghafar SS, Oh L, Lau KH, Thirunavakarasu T, Sedan A, Ibrahim K, Chan A, Chin TF, et al: Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging. Cancer. 123:4207–4214. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Daniel S, Nylander V, Ingerslev LR, Zhong L, Fabre O, Clifford B, Johnston K, Cohn RJ, Barres R and Simar D: T cell epigenetic remodeling and accelerated epigenetic aging are linked to long-term immune alterations in childhood cancer survivors. Clin Epigenetics. 10:1382018. View Article : Google Scholar : PubMed/NCBI | |
|
Sulicka-Grodzicka J, Surdacki A, Seweryn M, Mikołajczyk T, Rewiuk K, Guzik T and Grodzicki T: Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging? Cancer Med. 10:1772–1782. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Rossi F, Di Paola A, Pota E, Argenziano M, Di Pinto D, Marrapodi MM, Di Leva C, Di Martino M and Tortora C: Biological aspects of inflamm-aging in childhood cancer survivors. Cancers (Basel). 13:49332021. View Article : Google Scholar : PubMed/NCBI | |
|
Smith WA, Li C, Nottage KA, Mulrooney DA, Armstrong GT, Lanctot JQ, Chemaitilly W, Laver JH, Srivastava DK, Robison LL, et al: Lifestyle and metabolic syndrome in adult survivors of childhood cancer: A report from the St. Jude lifetime cohort study. Cancer. 120:2742–2750. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Clemens E, van der Kooi ALF, Broer L, van Dulmen-den Broeder E, Visscher H, Kremer L, Tissing W, Loonen J, Ronckers CM, Pluijm SMF, et al: The influence of genetic variation on late toxicities in childhood cancer survivors: A review. Crit Rev Oncol Hematol. 126:154–167. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ross JA, Oeffinger KC, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y and Robison LL: Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Clin Oncol. 22:3558–3562. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ravera S, Vigliarolo T, Bruno S, Morandi F, Marimpietri D, Sabatini F, Dagnino M, Petretto A, Bartolucci M, Muraca M, et al: Identification of biochemical and molecular markers of early aging in childhood cancer survivors. Cancers (Basel). 13:52142021. View Article : Google Scholar : PubMed/NCBI | |
|
Su HI, Kwan B, Whitcomb BW, Shliakhsitsava K, Dietz AC, Stark SS, Martinez E, Sluss PM, Sammel MD and Natarajan L: Modeling variation in the reproductive lifespan of female adolescent and young adult cancer survivors using AMH. J Clin Endocrinol Metab. 105:2740–2751. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
George SA, Williamson Lewis R, Schirmer DA, Effinger KE, Spencer JB, Mertens AC and Meacham LR: Early detection of ovarian dysfunction by anti-mullerian hormone in adolescent and young adult-aged survivors of childhood cancer. J Adolesc Young Adult Oncol. 8:18–25. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Elchuri SV, Patterson BC, Brown M, Bedient C, Record E, Wasilewski-Masker K, Mertens AC and Meacham LR: Low anti-müllerian hormone in pediatric cancer survivors in the early years after gonadotoxic therapy. J Pediatr Adolesc Gynecol. 29:393–399. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
de Vet A, Laven JS, de Jong FH, Themmen AP and Fauser BC: Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril. 77:357–362. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
van Dorp W, van den Heuvel-Eibrink MM, Stolk L, Pieters R, Uitterlinden AG, Visser JA and Laven JS: Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum Reprod. 28:1069–1076. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, et al: Effect of genetic variation in CYP450 on gonadal impairment in a european cohort of female childhood cancer survivors, based on a candidate gene approach: Results from the PanCareLIFE study. Cancers (Basel). 13:45982021. View Article : Google Scholar : PubMed/NCBI | |
|
Salas C, Niembro A, Lozano V, Gallardo E, Molina B, Sánchez S, Ramos S, Carnevale A, Pérez-Vera P, Rivera Luna R and Frias S: Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors. Environ Mol Mutagen. 53:271–280. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Smith LM, Evans JW, Mori M and Brown JM: The frequency of translocations after treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 24:737–742. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Song N, Li Z, Qin N, Howell CR, Wilson CL, Easton J, Mulder HL, Edmonson MN, Rusch MC, Zhang J, et al: Shortened leukocyte telomere length associates with an increased prevalence of chronic health conditions among survivors of childhood cancer: A report from the St. Jude lifetime cohort. Clin Cancer Res. 26:2362–2371. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Van Den Berg D, Hwang AE, Weisenberger D, Triche T, Nathwani BN, Conti DV, Siegmund K, Mack TM, Horvath S and Cozen W: DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin. Leuk Lymphoma. 60:1429–1437. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lipshultz SE, Anderson LM, Miller TL, Gerschenson M, Stevenson KE, Neuberg DS, Franco VI, LiButti DE, Silverman LB, Vrooman LM, et al: Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors. Cancer. 22:946–953. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Krull KR, Hardy KK, Kahalley LS, Schuitema I and Kesler SR: Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. J Clin Oncol. 36:2181–2189. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong GT, Reddick WE, Petersen RC, Santucci A, Zhang N, Srivastava D, Ogg RJ, Hillenbrand CM, Sabin N, Krasin MJ, et al: Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst. 105:899–907. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Krull KR, Sabin ND, Reddick WE, Zhu L, Armstrong GT, Green DM, Arevalo AR, Krasin MJ, Srivastava DK, Robison LL and Hudson MM: Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma. J Clin Oncol. 30:3618–3624. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Guida JL, Ahles TA, Belsky D, Campisi J, Cohen HJ, DeGregori J, Fuldner R, Ferrucci L, Gallicchio L, Gavrilov L, et al: Measuring aging and identifying aging phenotypes in cancer survivors. J Natl Cancer Inst. 111:1245–1254. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Guida JL, Agurs-Collins T, Ahles TA, Campisi J, Dale W, Demark-Wahnefried W, Dietrich J, Fuldner R, Gallicchio L, Green PA, et al: Strategies to prevent or remediate cancer and treatment-related aging. J Natl Cancer Inst. 113:112–122. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
van Kalsbeek RJ, van der Pal HJH, Kremer LCM, Bardi E, Brown MC, Effeney R, Winther JF, Follin C, den Hartogh J, Haupt R, et al: European PanCareFollowUp recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer. Eur J Cancer. 154:316–328. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Trama A, Bernasconi A, Botta L, Byrne J, Grabow D, Reulen RC, Calaminus G and Terenziani M: Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort. Pediatr Blood Cancer. 69:e299912022. View Article : Google Scholar : PubMed/NCBI | |
|
Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, et al: The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: A cohort from 12 European countries. Eur J Epidemiol. 33:335–349. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Braam KI, van der Torre P, Takken T, Veening MA, van Dulmen-den Broeder E and Kaspers GJ: Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database Syst Rev. 3:CD0087962016.PubMed/NCBI | |
|
Wiley CD and Campisi J: The metabolic roots of senescence: Mechanisms and opportunities for intervention. Nat Metab. 3:1290–1301. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lee MB, Hill CM, Bitto A and Kaeberlein M: Antiaging diets: Separating fact from fiction. Science. 374:eabe73652021. View Article : Google Scholar : PubMed/NCBI |
